News

A compound in avocados may ultimately offer a route to better leukemia treatment, says a new University of Guelph study.

A study has reported that after receiving either the Pfizer or AstraZeneca vaccine, 1 in 4 people experienced mild, short-lived systemic side effects, with headache, fatigue and tenderness the most common symptoms.

In up to 10% of all myocardial infarctions, no obvious cause is found in the coronary artery. A new study suggests that early magnetic resonance imaging of the heart can greatly increase the rate of diagnosis.

Researchers have found that the combination of inexpensive oral medications may be able to treat fatigue-inducing anemias caused by chronic diseases and inflammation.

Drugs used to treat hepatitis C boosted remdesivir's ability to inhibit SARS-CoV-2 in cell cultures, according to a new study.

Researchers have used computer modeling to reveal that one of the three mutations that make SARS-CoV-2 variant B.1.351 different from the original reduces the virus’ binding to human cells but potentially allows it to escape some antibodies.

Researchers have designed a novel potential treatment for COVID-19. The approach exploits the use of nanoparticles to "capture" SARS-CoV-2 so that the body's own immune system can locate and destroy it.

The resistance of cancer cells to chemotherapy is marked by specific changes in certain proteins. Researchers have discovered one such altered protein "DUSP16" plays an important role in response to chemotherapeutic drugs and thus propose that it could be used as a biomarker for sensitivity to chemotherapy treatment.

According to a study, 1 in 5 pharmacies refuse to dispense buprenorphine, a vital medication that treats addiction.

A new study shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.